A. Menarini Diagnostics v F. Hoffmann-La Roche (CoA, 11 March 2026)

Date	11 March 2026
Court	CoA
Division	Luxembourg (LU)
Type of action	Appeal RoP220.1
Case number(s)	UPC_CoA_934/2025
Registry reference	UPC-COA-0000934/2025
Parties	A. Menarini Diagnostics S.r.l., Berlin-Chemie AG, A. Menarini Diagnostics Frankreich SASU v. F. Hoffmann- La Roche AG, Roche Diabetes Care GmbH

Summary pending review. Official UPC registry metadata imported on 24 September 2026.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

English summary awaiting review. Read the French case note.

Source and translations

Official source: Unified Patent Court registry link recorded in the record
Original language: not recorded
Translation available: no translation recorded the firm’s French record is a summary, not a translation
Date checked: not recorded

Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

UPC_CoA_934/2025 official number

Follow this case

First instance cited in the decision: UPC_CFI_712/2025

Parties

claimantA. Menarini Diagnostics S.r.l.Follow this party
claimantBerlin-Chemie AGFollow this party
claimantA. Menarini Diagnostics Frankreich SASUFollow this party
defendantF. Hoffmann- La Roche AGnormalised name: F. Hoffmann-La Roche AG7 decisions in the corpus Follow this party
defendantRoche Diabetes Care GmbH14 decisions in the corpus Follow this party

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

1 October 2025 F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 1 October 2025) Application RoP262A · UPC_CFI_712/2025
La division réserve à un cercle restreint les informations confidentielles de l'opposition des défenderesses, avec l'accord des parties, et précise que l'interdiction d'usage ne vise pas les informations déjà connues hors de la procédure.
5 December 2025 F. Hoffmann-La Roche v A.Menarini Diagnostics (CFI, 5 December 2025) Application for provisional measures · UPC_CFI_712/2025
La demande est accueillie pour l'essentiel : la contrefaçon littérale des revendications 1 et 16 est suffisamment certaine, la validité suffisamment assurée et l'urgence établie, la division prononce une injonction couvrant la fabrication, la remise des produits à un huissier et des informations, sans garantie, les fra…
11 March 2026 A. Menarini Diagnostics v F. Hoffmann-La Roche (CoA, 11 March 2026) Appeal RoP220.1 · UPC_CoA_934/2025 · appeal, first-instance number cited in the decision

What the record states

Nature of the act: Appeal RoP220.1
Outcome (Dhenne Avocats summary): La cour d'appel autorise le désistement de la demande de mesures provisoires de Roche après transaction, déclare la procédure close, annule l'audience du 18 juin 2026 et ne statue pas sur les frais, conformément à l'accord des parties.
Appeal: Decision of the Court of Appeal (first instance cited: UPC_CFI_712/2025).
Instance: Court of Appeal decision.

Patents mentioned

EP 1 962 668 mentioned in: Dhenne Avocats analysis Follow this patent

Related decisions cited in the analyses

F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 25 March 2026) cited in this record
F. Hoffmann-La Roche v A.Menarini Diagnostics (CFI, 5 December 2025) cited in this record

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

Publication	Role in the dispute	Family	Standard and declaration	Pool	Sources
`EP 1 962 668`	Mentioned in the analysis (role not qualified) Also mentioned in 3 other decision(s): F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 25 March 2026) · F. Hoffmann-La Roche v A.Menarini Diagnostics (CFI, 5 December 2025) · F. Hoffmann-La Roche v A. Menarini Diagnostics (CFI, 1 October 2025)	not recorded	not recorded	not recorded	Espacenet links not checked mentioned in: Dhenne Avocats analysis

The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.